ReviewFrontiers in pharmacology2023

Hypoglycemic medicines in the treatment of Alzheimer's disease: Pathophysiological links between AD and glucose metabolism.

Yixuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.